﻿<?xml version="1.0" encoding="UTF-8"?>
<records>
  <record>
    <language>eng</language>
    <publisher>Science and Education Publishing</publisher>
    <journalTitle>American Journal of Medical Case Reports</journalTitle>
    <eissn>2374-216X</eissn>
    <publicationDate>2019-07-14</publicationDate>
    <volume>7</volume>
    <issue>9</issue>
    <startPage>191</startPage>
    <endPage>192</endPage>
    <doi>10.12691/ajmcr-7-9-2</doi>
    <publisherRecordId>AJMCR2019792</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Lactobacillus Bacteremia in a Critically Ill Patient</title>
    <authors>
      <author>
        <name>Mohamed Saad Eldin</name>
        <email>msaadeld@conemaugh.org</email>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Sadaquat Liaqat</name>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Khaled Awad</name>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Salah Aldergash</name>
        <affiliationId>1</affiliationId>
      </author>
    </authors>
    <affiliationsList>
      <affiliationName affiliationId="1">Department of Internal Medicine, Conemaugh Memorial Medical Center, Johnstown, PA, USA</affiliationName>
    </affiliationsList>
    <abstract language="eng">Lactobacilli are normal commensal bacteria of human. They can cause fatal infections in an immunocompromised host. We present a case of an immunocompromised patient with stage IV non-small cell lung cancer receiving Nivolumab who had high grade lactobacillus bacteremia and fungal blood stream infection.</abstract>
    <fullTextUrl format="pdf">http://pubs.sciepub.com/ajmcr/7/9/2/ajmcr-7-9-2.pdf</fullTextUrl>
    <keywords language="eng">
      <keyword>lactobacilli</keyword>
      <keyword>Nivolumab</keyword>
      <keyword>lactobacillus acidophilus</keyword>
    </keywords>
  </record>
</records>